Davis Polk advised Bausch Health Companies Inc. in connection with the separation of its eye health business into a new publicly traded company, Bausch + Lomb...
Bausch + Lomb’s $630 Million Initial Public Offering
ADQ’s $740 Million Acquisition of Amoun Pharmaceutical Company
Wachtell, Lipton, Rosen & Katz acted as legal advisor to Bausch Health in the transaction. Bausch Health Companies Inc. (NYSE/TSX: BHC) announced that it and certain of...